Raedler, L. A. (2016). Tresiba (Insulin Degludec Injection) and Ryzodeg 70/30 (Insulin Degludec and Insulin Aspart Injection): Two New Insulin Analogs for Glycemic Control in Diabetes Mellitus. Am Health Drug Benefits.
シカゴスタイル引用形Raedler, Lisa A. "Tresiba (Insulin Degludec Injection) and Ryzodeg 70/30 (Insulin Degludec and Insulin Aspart Injection): Two New Insulin Analogs for Glycemic Control in Diabetes Mellitus." Am Health Drug Benefits 2016.
MLA引用形式Raedler, Lisa A. "Tresiba (Insulin Degludec Injection) and Ryzodeg 70/30 (Insulin Degludec and Insulin Aspart Injection): Two New Insulin Analogs for Glycemic Control in Diabetes Mellitus." Am Health Drug Benefits 2016.
警告: この引用は必ずしも正確ではありません.